Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (MAMBO) Phase I

Clinical trial NCT06503848 · RECRUITING

Trial details

NCT number: NCT06503848
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Status: RECRUITING
Study type: OBSERVATIONAL

Migraine Disorders

Start date: 2024-01-25
Primary completion: 2024-12-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.